Autolus Therapeutics Long Term Deferred Charges (Quarterly) Analysis

Autolus Therapeutics Plc (AUTL)

1.675 +0.04 (+2.13%) USD | NASDAQ | Feb 20, 16:00

1.675 0.00 (0.00%) After-Hours: 17:54

View Long Term Deferred Charges (Quarterly) for AUTL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Biodexa Pharmaceuticals Plc	--
NuCana Plc	--
Mereo BioPharma Group Plc	--
Bicycle Therapeutics Plc	--
DBV Technologies SA	--